(CAH) Cardinal Health - Ratings and Ratios
Pharmaceuticals, Medical Supplies, Surgical Products, Healthcare Products, Laboratory Products
CAH EPS (Earnings per Share)
CAH Revenue
Description: CAH Cardinal Health
Cardinal Health Inc (NYSE:CAH) is a healthcare services and products company operating globally, providing customized solutions to various healthcare providers and patients. The companys diversified business model is reflected in its two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
Key Performance Indicators (KPIs) for Cardinal Health Inc include revenue growth, gross margin, and operating cash flow. With a market capitalization of approximately $39.4 billion, the companys financial health is crucial to its ability to invest in growth opportunities and return value to shareholders. The return on equity (RoE) of -50.14% indicates significant challenges in generating profits from shareholder equity, suggesting potential areas for improvement in operational efficiency or strategic direction.
The companys product and service offerings are broad, encompassing distribution of pharmaceuticals, medical supplies, and Cardinal Health branded products, as well as services like pharmacy management and supply chain solutions. This diversification can help mitigate risks associated with any single product or market. However, it also requires effective management across multiple business lines to maintain profitability.
From a valuation perspective, Cardinal Health Incs price-to-earnings (P/E) ratio of 25.85 and forward P/E of 17.51 suggest that the market expects earnings growth. The significant difference between the current and forward P/E ratios may indicate anticipated improvements in earnings. Analyzing these metrics in the context of industry peers and the broader healthcare sector can provide insights into whether CAH is undervalued or overvalued.
Cardinal Healths operational efficiency, ability to innovate, and capacity to manage its supply chain effectively will be critical in maintaining its competitive edge. The companys commitment to providing a wide range of healthcare products and services positions it as a significant player in the healthcare distribution and services market.
Additional Sources for CAH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CAH Stock Overview
Market Cap in USD | 39,365m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception | 1987-12-31 |
CAH Stock Ratings
Growth Rating | 97.0 |
Fundamental | 38.6 |
Dividend Rating | 45.6 |
Rel. Strength | 88.2 |
Analysts | 4.12 of 5 |
Fair Price Momentum | 199.19 USD |
Fair Price DCF | 214.10 USD |
CAH Dividends
Dividend Yield 12m | 1.43% |
Yield on Cost 5y | 4.37% |
Annual Growth 5y | -4.84% |
Payout Consistency | 92.1% |
Payout Ratio | 25.4% |
CAH Growth Ratios
Growth Correlation 3m | 90.5% |
Growth Correlation 12m | 97.4% |
Growth Correlation 5y | 94.9% |
CAGR 5y | 27.97% |
CAGR/Max DD 5y | 1.13 |
Sharpe Ratio 12m | 2.34 |
Alpha | 61.09 |
Beta | 0.349 |
Volatility | 22.28% |
Current Volume | 1253.6k |
Average Volume 20d | 2145.3k |
Stop Loss | 154.7 (-3%) |
As of July 18, 2025, the stock is trading at USD 159.46 with a total of 1,253,554 shares traded.
Over the past week, the price has changed by -1.67%, over one month by -3.01%, over three months by +18.73% and over the past year by +68.77%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Cardinal Health (NYSE:CAH) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.56 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CAH is around 199.19 USD . This means that CAH is currently undervalued and has a potential upside of +24.92% (Margin of Safety).
Cardinal Health has received a consensus analysts rating of 4.12. Therefore, it is recommended to buy CAH.
- Strong Buy: 9
- Buy: 2
- Hold: 5
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, CAH Cardinal Health will be worth about 216.5 in July 2026. The stock is currently trading at 159.46. This means that the stock has a potential upside of +35.76%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 172.2 | 8% |
Analysts Target Price | 155.5 | -2.5% |
ValueRay Target Price | 216.5 | 35.8% |